Oligonucleotide compositions and methods thereof
US11634710B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Feb 4, 2020 |
| Grant date | Apr 25, 2023 |
| Priority date | — |
| Expiry date | Aug 25, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/346
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Among other things, the present disclosure relates to designed oligonucleotides, compositions, and methods thereof. In some embodiments, provided oligonucleotide compositions provide altered splicing of a transcript. In some embodiments, provided oligonucleotide compositions have low toxicity. In some embodiments, provided oligonucleotide compositions provide improved protein binding profiles. In some embodiments, provided oligonucleotide compositions have improved delivery. In some embodiments, provided oligonucleotide compositions have improved uptake. In some embodiments, the present disclosure provides methods for treatment of diseases using provided oligonucleotide compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.